{
    "Trade/Device Name(s)": [
        "Salivabuse\u00ae Liquid Oral Fluid Control",
        "Salivabuse\u00ae Liquid Control Oral Fluid",
        "Salivabuse\u00ae Liquid Control Oral Fluid, AU/NZ"
    ],
    "Submitter Information": "Biochemical Diagnostics, Inc.",
    "510(k) Number": "K132688",
    "Predicate Device Reference 510(k) Number(s)": [
        "K103227"
    ],
    "Regulatory Class": "Class I, reserved",
    "Product Code(s)": [
        "DIF"
    ],
    "Summary Letter Date": "December 16, 2013",
    "Summary Letter Received Date": "November 8, 2013",
    "Submission Date": "November 1, 2013",
    "Regulation Number(s)": [
        "21 CFR 862.3280"
    ],
    "Regulation Name(s)": [
        "Clinical toxicology control material"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Amphetamines",
        "Methamphetamines",
        "Cocaine",
        "Benzoylecgonine",
        "Opiates",
        "PCP",
        "Cannabinoids",
        "Barbiturates",
        "Benzodiazepines",
        "Methadone",
        "Cotinine",
        "Ethanol"
    ],
    "Specimen Type(s)": [
        "Oral fluid (synthetic)"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "GC/MS",
        "LC/MS",
        "Immunoassay"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Control",
        "Quality control material"
    ],
    "Document Summary": "FDA 510(k) summary for Salivabuse Liquid Oral Fluid Control quality control materials for oral fluid toxicology testing.",
    "Indications for Use Summary": "Intended for in vitro diagnostic use as quality controls to monitor the precision of laboratory oral fluid toxicology testing procedures for specified analytes.",
    "fda_folder": "Toxicology"
}